Financials
- Market Capitalization 7.44 M
- Employee 8
- Founded 2017
- CEO N/A
- Website www.cnspharma.com
- Headquarter Nevada, United States
- FIGI BBG00PM24T16
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.15
Rapporto prezzo/fatturato
-909.61
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4874 | ELOX Eloxx Pharmaceuticals, Inc. | 11.35 USD | -3.90% | -5.42% | -23.57% | +13.50% | 7.81 M USD | ||
| 4882 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 5.97 USD | -0.67% | +1.02% | +18.45% | +282.69% | 7.73 M USD | ||
| 4894 | BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.78 USD | 0.00% | -8.25% | -20.25% | -36.47% | 7.26 M USD | ||
| 4898 | IMRN Immuron Limited - American Depositary Shares | 1.22 USD | -0.81% | +5.17% | +5.17% | -32.97% | 7.14 M USD |